nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—Decreased appetite—Ergocalciferol—osteoporosis	0.00325	0.00491	CcSEcCtD
Pasireotide—Pain in extremity—Conjugated Estrogens—osteoporosis	0.00323	0.00488	CcSEcCtD
Pasireotide—Oedema peripheral—Raloxifene—osteoporosis	0.00323	0.00487	CcSEcCtD
Pasireotide—Constipation—Ergocalciferol—osteoporosis	0.0032	0.00483	CcSEcCtD
Pasireotide—Oedema peripheral—Ibandronate—osteoporosis	0.00319	0.00483	CcSEcCtD
Pasireotide—Influenza—Pamidronate—osteoporosis	0.00317	0.00479	CcSEcCtD
Pasireotide—Anaemia—Etidronic acid—osteoporosis	0.00314	0.00475	CcSEcCtD
Pasireotide—Abdominal pain upper—Zoledronate—osteoporosis	0.00306	0.00463	CcSEcCtD
Pasireotide—Hypokalaemia—Zoledronate—osteoporosis	0.00305	0.00461	CcSEcCtD
Pasireotide—Asthenia—Calcium Acetate—osteoporosis	0.00303	0.00458	CcSEcCtD
Pasireotide—Nasopharyngitis—Zoledronate—osteoporosis	0.003	0.00453	CcSEcCtD
Pasireotide—Pruritus—Calcium Acetate—osteoporosis	0.00299	0.00452	CcSEcCtD
Pasireotide—Alopecia—Estropipate—osteoporosis	0.00299	0.00451	CcSEcCtD
Pasireotide—Alopecia—Alendronate—osteoporosis	0.00294	0.00445	CcSEcCtD
Pasireotide—Hypokalaemia—Conjugated Estrogens—osteoporosis	0.00294	0.00444	CcSEcCtD
Pasireotide—Abdominal distension—Zoledronate—osteoporosis	0.00292	0.00441	CcSEcCtD
Pasireotide—Influenza—Zoledronate—osteoporosis	0.0029	0.00438	CcSEcCtD
Pasireotide—Arthralgia—Etidronic acid—osteoporosis	0.0029	0.00438	CcSEcCtD
Pasireotide—Diarrhoea—Calcium Acetate—osteoporosis	0.00289	0.00437	CcSEcCtD
Pasireotide—Alopecia—Ibandronate—osteoporosis	0.00287	0.00433	CcSEcCtD
Pasireotide—Back pain—Estropipate—osteoporosis	0.00285	0.0043	CcSEcCtD
Pasireotide—Abdominal distension—Conjugated Estrogens—osteoporosis	0.00281	0.00425	CcSEcCtD
Pasireotide—Dizziness—Calcium Acetate—osteoporosis	0.0028	0.00423	CcSEcCtD
Pasireotide—Influenza—Conjugated Estrogens—osteoporosis	0.00279	0.00422	CcSEcCtD
Pasireotide—Back pain—Ibandronate—osteoporosis	0.00273	0.00412	CcSEcCtD
Pasireotide—Vomiting—Calcium Acetate—osteoporosis	0.00269	0.00406	CcSEcCtD
Pasireotide—Asthenia—Ergocalciferol—osteoporosis	0.00268	0.00405	CcSEcCtD
Pasireotide—Anaemia—Alendronate—osteoporosis	0.00268	0.00405	CcSEcCtD
Pasireotide—Vertigo—Estropipate—osteoporosis	0.00264	0.004	CcSEcCtD
Pasireotide—Oedema peripheral—Risedronate—osteoporosis	0.00263	0.00398	CcSEcCtD
Pasireotide—Anaemia—Ibandronate—osteoporosis	0.00261	0.00394	CcSEcCtD
Pasireotide—Vertigo—Alendronate—osteoporosis	0.0026	0.00394	CcSEcCtD
Pasireotide—Pain in extremity—Estradiol—osteoporosis	0.00258	0.00391	CcSEcCtD
Pasireotide—Vertigo—Raloxifene—osteoporosis	0.00256	0.00387	CcSEcCtD
Pasireotide—Vertigo—Ibandronate—osteoporosis	0.00254	0.00383	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Etidronic acid—osteoporosis	0.00253	0.00382	CcSEcCtD
Pasireotide—Hyperglycaemia—Conjugated Estrogens—osteoporosis	0.00252	0.0038	CcSEcCtD
Pasireotide—Nausea—Calcium Acetate—osteoporosis	0.00251	0.0038	CcSEcCtD
Pasireotide—Myalgia—Estropipate—osteoporosis	0.00251	0.00379	CcSEcCtD
Pasireotide—Arthralgia—Estropipate—osteoporosis	0.00251	0.00379	CcSEcCtD
Pasireotide—Anxiety—Estropipate—osteoporosis	0.0025	0.00377	CcSEcCtD
Pasireotide—Myalgia—Alendronate—osteoporosis	0.00247	0.00373	CcSEcCtD
Pasireotide—Hypertension—Ibandronate—osteoporosis	0.00244	0.00368	CcSEcCtD
Pasireotide—Myalgia—Raloxifene—osteoporosis	0.00243	0.00367	CcSEcCtD
Pasireotide—Arthralgia—Raloxifene—osteoporosis	0.00243	0.00367	CcSEcCtD
Pasireotide—Alopecia—Ethinyl Estradiol—osteoporosis	0.00242	0.00366	CcSEcCtD
Pasireotide—Myalgia—Ibandronate—osteoporosis	0.0024	0.00363	CcSEcCtD
Pasireotide—Arthralgia—Ibandronate—osteoporosis	0.0024	0.00363	CcSEcCtD
Pasireotide—Anxiety—Ibandronate—osteoporosis	0.00239	0.00362	CcSEcCtD
Pasireotide—Hypertension—Calcitriol—osteoporosis	0.00239	0.0036	CcSEcCtD
Pasireotide—Constipation—Etidronic acid—osteoporosis	0.00237	0.00359	CcSEcCtD
Pasireotide—Dry skin—Estradiol—osteoporosis	0.00237	0.00358	CcSEcCtD
Pasireotide—Abdominal pain upper—Estradiol—osteoporosis	0.00236	0.00357	CcSEcCtD
Pasireotide—Myalgia—Calcitriol—osteoporosis	0.00235	0.00355	CcSEcCtD
Pasireotide—Anxiety—Calcitriol—osteoporosis	0.00234	0.00354	CcSEcCtD
Pasireotide—Nasopharyngitis—Estradiol—osteoporosis	0.00231	0.00349	CcSEcCtD
Pasireotide—Back pain—Ethinyl Estradiol—osteoporosis	0.00231	0.00349	CcSEcCtD
Pasireotide—Oedema peripheral—Zoledronate—osteoporosis	0.00229	0.00345	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Estradiol—osteoporosis	0.00228	0.00344	CcSEcCtD
Pasireotide—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00227	0.00343	CcSEcCtD
Pasireotide—Back pain—Risedronate—osteoporosis	0.00225	0.0034	CcSEcCtD
Pasireotide—Abdominal distension—Estradiol—osteoporosis	0.00225	0.0034	CcSEcCtD
Pasireotide—Alopecia—Pamidronate—osteoporosis	0.00224	0.00339	CcSEcCtD
Pasireotide—Influenza—Estradiol—osteoporosis	0.00223	0.00338	CcSEcCtD
Pasireotide—Nausea—Ergocalciferol—osteoporosis	0.00222	0.00335	CcSEcCtD
Pasireotide—Oedema peripheral—Conjugated Estrogens—osteoporosis	0.0022	0.00333	CcSEcCtD
Pasireotide—Abdominal pain—Etidronic acid—osteoporosis	0.0022	0.00332	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Estropipate—osteoporosis	0.00219	0.00331	CcSEcCtD
Pasireotide—Insomnia—Estropipate—osteoporosis	0.00217	0.00328	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Alendronate—osteoporosis	0.00216	0.00326	CcSEcCtD
Pasireotide—Anaemia—Risedronate—osteoporosis	0.00215	0.00325	CcSEcCtD
Pasireotide—Back pain—Pamidronate—osteoporosis	0.00214	0.00323	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.00212	0.0032	CcSEcCtD
Pasireotide—Insomnia—Raloxifene—osteoporosis	0.0021	0.00318	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.0021	0.00317	CcSEcCtD
Pasireotide—Vertigo—Risedronate—osteoporosis	0.00209	0.00316	CcSEcCtD
Pasireotide—Insomnia—Ibandronate—osteoporosis	0.00208	0.00315	CcSEcCtD
Pasireotide—Fatigue—Estropipate—osteoporosis	0.00207	0.00313	CcSEcCtD
Pasireotide—SSTR5—GPCR ligand binding—PTH—osteoporosis	0.00206	0.00609	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.00205	0.0031	CcSEcCtD
Pasireotide—Constipation—Estropipate—osteoporosis	0.00205	0.0031	CcSEcCtD
Pasireotide—Alopecia—Zoledronate—osteoporosis	0.00205	0.0031	CcSEcCtD
Pasireotide—Anaemia—Pamidronate—osteoporosis	0.00204	0.00309	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—PTH1R—osteoporosis	0.00204	0.00604	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—CALCR—osteoporosis	0.00204	0.00604	CbGpPWpGaD
Pasireotide—Insomnia—Calcitriol—osteoporosis	0.00204	0.00308	CcSEcCtD
Pasireotide—Anxiety—Ethinyl Estradiol—osteoporosis	0.00202	0.00306	CcSEcCtD
Pasireotide—Constipation—Alendronate—osteoporosis	0.00202	0.00306	CcSEcCtD
Pasireotide—Hyperglycaemia—Estradiol—osteoporosis	0.00202	0.00304	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—CALCR—osteoporosis	0.00201	0.00594	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PTH1R—osteoporosis	0.00201	0.00594	CbGpPWpGaD
Pasireotide—Hypertension—Risedronate—osteoporosis	0.00201	0.00303	CcSEcCtD
Pasireotide—SSTR3—GPCR ligand binding—PTHLH—osteoporosis	0.002	0.00593	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—CNR2—osteoporosis	0.002	0.00593	CbGpPWpGaD
Pasireotide—Decreased appetite—Ibandronate—osteoporosis	0.002	0.00303	CcSEcCtD
Pasireotide—SSTR1—G alpha (i) signalling events—ADCY5—osteoporosis	0.00199	0.00588	CbGpPWpGaD
Pasireotide—Fatigue—Ibandronate—osteoporosis	0.00199	0.003	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—MGLL—osteoporosis	0.00198	0.00586	CbGpPWpGaD
Pasireotide—Myalgia—Risedronate—osteoporosis	0.00198	0.00299	CcSEcCtD
Pasireotide—Arthralgia—Risedronate—osteoporosis	0.00198	0.00299	CcSEcCtD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.00198	0.00586	CbGpPWpGaD
Pasireotide—Alopecia—Conjugated Estrogens—osteoporosis	0.00197	0.00298	CcSEcCtD
Pasireotide—Anxiety—Risedronate—osteoporosis	0.00197	0.00298	CcSEcCtD
Pasireotide—Constipation—Ibandronate—osteoporosis	0.00197	0.00298	CcSEcCtD
Pasireotide—Pruritus—Etidronic acid—osteoporosis	0.00196	0.00297	CcSEcCtD
Pasireotide—Gastrointestinal pain—Estropipate—osteoporosis	0.00196	0.00297	CcSEcCtD
Pasireotide—Decreased appetite—Calcitriol—osteoporosis	0.00196	0.00296	CcSEcCtD
Pasireotide—Back pain—Zoledronate—osteoporosis	0.00195	0.00295	CcSEcCtD
Pasireotide—Gastrointestinal pain—Alendronate—osteoporosis	0.00193	0.00292	CcSEcCtD
Pasireotide—Constipation—Calcitriol—osteoporosis	0.00193	0.00291	CcSEcCtD
Pasireotide—SSTR1—GPCR ligand binding—PTHLH—osteoporosis	0.00192	0.00569	CbGpPWpGaD
Pasireotide—Hypertension—Pamidronate—osteoporosis	0.00191	0.00288	CcSEcCtD
Pasireotide—Gastrointestinal pain—Raloxifene—osteoporosis	0.0019	0.00287	CcSEcCtD
Pasireotide—Diarrhoea—Etidronic acid—osteoporosis	0.0019	0.00287	CcSEcCtD
Pasireotide—Abdominal pain—Estropipate—osteoporosis	0.0019	0.00287	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—PTH—osteoporosis	0.0019	0.00562	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—WNT1—osteoporosis	0.00188	0.00558	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Ibandronate—osteoporosis	0.00188	0.00285	CcSEcCtD
Pasireotide—Myalgia—Pamidronate—osteoporosis	0.00188	0.00284	CcSEcCtD
Pasireotide—Arthralgia—Pamidronate—osteoporosis	0.00188	0.00284	CcSEcCtD
Pasireotide—Back pain—Conjugated Estrogens—osteoporosis	0.00188	0.00284	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—MGLL—osteoporosis	0.00188	0.00555	CbGpPWpGaD
Pasireotide—Anxiety—Pamidronate—osteoporosis	0.00188	0.00283	CcSEcCtD
Pasireotide—Abdominal pain—Alendronate—osteoporosis	0.00187	0.00283	CcSEcCtD
Pasireotide—Anaemia—Zoledronate—osteoporosis	0.00187	0.00282	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—CALCR—osteoporosis	0.00185	0.00549	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PTH1R—osteoporosis	0.00185	0.00549	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—CNR2—osteoporosis	0.00185	0.00547	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Calcitriol—osteoporosis	0.00184	0.00279	CcSEcCtD
Pasireotide—Abdominal pain—Raloxifene—osteoporosis	0.00184	0.00278	CcSEcCtD
Pasireotide—Abdominal pain—Ibandronate—osteoporosis	0.00182	0.00275	CcSEcCtD
Pasireotide—Vertigo—Zoledronate—osteoporosis	0.00181	0.00274	CcSEcCtD
Pasireotide—SSTR3—Peptide ligand-binding receptors—POMC—osteoporosis	0.00181	0.00535	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—MGLL—osteoporosis	0.0018	0.00533	CbGpPWpGaD
Pasireotide—Abdominal pain—Calcitriol—osteoporosis	0.00178	0.00269	CcSEcCtD
Pasireotide—Vomiting—Etidronic acid—osteoporosis	0.00177	0.00267	CcSEcCtD
Pasireotide—SSTR3—GPCR ligand binding—CALCA—osteoporosis	0.00177	0.00522	CbGpPWpGaD
Pasireotide—SSTR5—G alpha (i) signalling events—ADCY5—osteoporosis	0.00176	0.00522	CbGpPWpGaD
Pasireotide—Oedema peripheral—Estradiol—osteoporosis	0.00176	0.00266	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—MGLL—osteoporosis	0.00176	0.0052	CbGpPWpGaD
Pasireotide—Vertigo—Conjugated Estrogens—osteoporosis	0.00175	0.00264	CcSEcCtD
Pasireotide—Hypertension—Zoledronate—osteoporosis	0.00174	0.00263	CcSEcCtD
Pasireotide—Headache—Etidronic acid—osteoporosis	0.00174	0.00263	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—WNT1—osteoporosis	0.00174	0.00515	CbGpPWpGaD
Pasireotide—SSTR1—Peptide ligand-binding receptors—POMC—osteoporosis	0.00173	0.00513	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00173	0.00261	CcSEcCtD
Pasireotide—Asthenia—Estropipate—osteoporosis	0.00172	0.0026	CcSEcCtD
Pasireotide—Myalgia—Zoledronate—osteoporosis	0.00172	0.0026	CcSEcCtD
Pasireotide—Arthralgia—Zoledronate—osteoporosis	0.00172	0.0026	CcSEcCtD
Pasireotide—Insomnia—Risedronate—osteoporosis	0.00172	0.00259	CcSEcCtD
Pasireotide—Anxiety—Zoledronate—osteoporosis	0.00171	0.00259	CcSEcCtD
Pasireotide—SSTR5—GPCR ligand binding—PTHLH—osteoporosis	0.0017	0.00504	CbGpPWpGaD
Pasireotide—Pruritus—Estropipate—osteoporosis	0.0017	0.00257	CcSEcCtD
Pasireotide—Asthenia—Alendronate—osteoporosis	0.0017	0.00256	CcSEcCtD
Pasireotide—SSTR1—GPCR ligand binding—CALCA—osteoporosis	0.00169	0.00501	CbGpPWpGaD
Pasireotide—Hypotension—Pamidronate—osteoporosis	0.00169	0.00255	CcSEcCtD
Pasireotide—Fatigue—Ethinyl Estradiol—osteoporosis	0.00168	0.00254	CcSEcCtD
Pasireotide—Pruritus—Alendronate—osteoporosis	0.00167	0.00253	CcSEcCtD
Pasireotide—Constipation—Ethinyl Estradiol—osteoporosis	0.00167	0.00252	CcSEcCtD
Pasireotide—Myalgia—Conjugated Estrogens—osteoporosis	0.00166	0.0025	CcSEcCtD
Pasireotide—Arthralgia—Conjugated Estrogens—osteoporosis	0.00166	0.0025	CcSEcCtD
Pasireotide—Asthenia—Ibandronate—osteoporosis	0.00165	0.0025	CcSEcCtD
Pasireotide—Anxiety—Conjugated Estrogens—osteoporosis	0.00165	0.00249	CcSEcCtD
Pasireotide—Nausea—Etidronic acid—osteoporosis	0.00165	0.00249	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00164	0.00248	CcSEcCtD
Pasireotide—Diarrhoea—Estropipate—osteoporosis	0.00164	0.00248	CcSEcCtD
Pasireotide—Fatigue—Risedronate—osteoporosis	0.00164	0.00247	CcSEcCtD
Pasireotide—Insomnia—Pamidronate—osteoporosis	0.00163	0.00247	CcSEcCtD
Pasireotide—Pruritus—Ibandronate—osteoporosis	0.00163	0.00246	CcSEcCtD
Pasireotide—SSTR2—G alpha (i) signalling events—ADCY5—osteoporosis	0.00163	0.00481	CbGpPWpGaD
Pasireotide—Constipation—Risedronate—osteoporosis	0.00162	0.00245	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—MGLL—osteoporosis	0.00162	0.0048	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.00162	0.00479	CbGpPWpGaD
Pasireotide—Diarrhoea—Alendronate—osteoporosis	0.00162	0.00245	CcSEcCtD
Pasireotide—Asthenia—Calcitriol—osteoporosis	0.00162	0.00244	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—MGLL—osteoporosis	0.0016	0.00472	CbGpPWpGaD
Pasireotide—Pruritus—Calcitriol—osteoporosis	0.0016	0.00241	CcSEcCtD
Pasireotide—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00159	0.00241	CcSEcCtD
Pasireotide—Diarrhoea—Raloxifene—osteoporosis	0.00159	0.00241	CcSEcCtD
Pasireotide—Dizziness—Estropipate—osteoporosis	0.00159	0.0024	CcSEcCtD
Pasireotide—Alopecia—Estradiol—osteoporosis	0.00158	0.00239	CcSEcCtD
Pasireotide—Diarrhoea—Ibandronate—osteoporosis	0.00158	0.00238	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—PTHLH—osteoporosis	0.00157	0.00465	CbGpPWpGaD
Pasireotide—Decreased appetite—Pamidronate—osteoporosis	0.00157	0.00237	CcSEcCtD
Pasireotide—Dizziness—Alendronate—osteoporosis	0.00156	0.00236	CcSEcCtD
Pasireotide—Fatigue—Pamidronate—osteoporosis	0.00156	0.00235	CcSEcCtD
Pasireotide—Gastrointestinal pain—Risedronate—osteoporosis	0.00155	0.00235	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—SOST—osteoporosis	0.00154	0.00457	CbGpPWpGaD
Pasireotide—Constipation—Pamidronate—osteoporosis	0.00154	0.00233	CcSEcCtD
Pasireotide—Diarrhoea—Calcitriol—osteoporosis	0.00154	0.00233	CcSEcCtD
Pasireotide—Hypotension—Zoledronate—osteoporosis	0.00154	0.00233	CcSEcCtD
Pasireotide—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00154	0.00233	CcSEcCtD
Pasireotide—Dizziness—Raloxifene—osteoporosis	0.00154	0.00232	CcSEcCtD
Pasireotide—SSTR5—Peptide ligand-binding receptors—POMC—osteoporosis	0.00154	0.00455	CbGpPWpGaD
Pasireotide—Vomiting—Estropipate—osteoporosis	0.00153	0.00231	CcSEcCtD
Pasireotide—SSTR3—G alpha (i) signalling events—POMC—osteoporosis	0.00153	0.00451	CbGpPWpGaD
Pasireotide—Dizziness—Ibandronate—osteoporosis	0.00152	0.0023	CcSEcCtD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.00151	0.00445	CbGpPWpGaD
Pasireotide—Back pain—Estradiol—osteoporosis	0.00151	0.00227	CcSEcCtD
Pasireotide—Headache—Estropipate—osteoporosis	0.0015	0.00227	CcSEcCtD
Pasireotide—Vomiting—Alendronate—osteoporosis	0.0015	0.00227	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.0015	0.00227	CcSEcCtD
Pasireotide—Abdominal pain—Risedronate—osteoporosis	0.0015	0.00227	CcSEcCtD
Pasireotide—SSTR5—GPCR ligand binding—CALCA—osteoporosis	0.0015	0.00444	CbGpPWpGaD
Pasireotide—Insomnia—Zoledronate—osteoporosis	0.00149	0.00225	CcSEcCtD
Pasireotide—Hypotension—Conjugated Estrogens—osteoporosis	0.00148	0.00224	CcSEcCtD
Pasireotide—Headache—Alendronate—osteoporosis	0.00148	0.00224	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—SOST—osteoporosis	0.00148	0.00438	CbGpPWpGaD
Pasireotide—Vomiting—Raloxifene—osteoporosis	0.00148	0.00224	CcSEcCtD
Pasireotide—Gastrointestinal pain—Pamidronate—osteoporosis	0.00148	0.00223	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—MGLL—osteoporosis	0.00147	0.00436	CbGpPWpGaD
Pasireotide—Vomiting—Ibandronate—osteoporosis	0.00146	0.00221	CcSEcCtD
Pasireotide—SSTR1—G alpha (i) signalling events—POMC—osteoporosis	0.00146	0.00433	CbGpPWpGaD
Pasireotide—Headache—Raloxifene—osteoporosis	0.00146	0.0022	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00145	0.00218	CcSEcCtD
Pasireotide—Headache—Ibandronate—osteoporosis	0.00144	0.00218	CcSEcCtD
Pasireotide—Insomnia—Conjugated Estrogens—osteoporosis	0.00144	0.00217	CcSEcCtD
Pasireotide—Vomiting—Calcitriol—osteoporosis	0.00143	0.00217	CcSEcCtD
Pasireotide—Decreased appetite—Zoledronate—osteoporosis	0.00143	0.00216	CcSEcCtD
Pasireotide—Nausea—Estropipate—osteoporosis	0.00143	0.00216	CcSEcCtD
Pasireotide—Abdominal pain—Pamidronate—osteoporosis	0.00143	0.00216	CcSEcCtD
Pasireotide—Fatigue—Zoledronate—osteoporosis	0.00142	0.00215	CcSEcCtD
Pasireotide—SSTR2—Peptide ligand-binding receptors—POMC—osteoporosis	0.00142	0.0042	CbGpPWpGaD
Pasireotide—Headache—Calcitriol—osteoporosis	0.00141	0.00213	CcSEcCtD
Pasireotide—Constipation—Zoledronate—osteoporosis	0.00141	0.00213	CcSEcCtD
Pasireotide—Nausea—Alendronate—osteoporosis	0.00141	0.00212	CcSEcCtD
Pasireotide—Vertigo—Estradiol—osteoporosis	0.0014	0.00211	CcSEcCtD
Pasireotide—Asthenia—Ethinyl Estradiol—osteoporosis	0.0014	0.00211	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—PTH1R—osteoporosis	0.0014	0.00413	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CALCR—osteoporosis	0.0014	0.00413	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—CALCA—osteoporosis	0.00139	0.0041	CbGpPWpGaD
Pasireotide—Nausea—Raloxifene—osteoporosis	0.00138	0.00209	CcSEcCtD
Pasireotide—Decreased appetite—Conjugated Estrogens—osteoporosis	0.00138	0.00208	CcSEcCtD
Pasireotide—Pruritus—Ethinyl Estradiol—osteoporosis	0.00138	0.00208	CcSEcCtD
Pasireotide—Fatigue—Conjugated Estrogens—osteoporosis	0.00137	0.00207	CcSEcCtD
Pasireotide—Nausea—Ibandronate—osteoporosis	0.00137	0.00207	CcSEcCtD
Pasireotide—SSTR3—GPCR downstream signaling—PTH—osteoporosis	0.00137	0.00404	CbGpPWpGaD
Pasireotide—Asthenia—Risedronate—osteoporosis	0.00136	0.00206	CcSEcCtD
Pasireotide—Constipation—Conjugated Estrogens—osteoporosis	0.00136	0.00205	CcSEcCtD
Pasireotide—Gastrointestinal pain—Zoledronate—osteoporosis	0.00135	0.00204	CcSEcCtD
Pasireotide—Hypertension—Estradiol—osteoporosis	0.00134	0.00203	CcSEcCtD
Pasireotide—Pruritus—Risedronate—osteoporosis	0.00134	0.00203	CcSEcCtD
Pasireotide—Nausea—Calcitriol—osteoporosis	0.00134	0.00202	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—CALCR—osteoporosis	0.00134	0.00396	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PTH1R—osteoporosis	0.00134	0.00396	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—CNR2—osteoporosis	0.00133	0.00394	CbGpPWpGaD
Pasireotide—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00133	0.00201	CcSEcCtD
Pasireotide—Myalgia—Estradiol—osteoporosis	0.00133	0.002	CcSEcCtD
Pasireotide—Arthralgia—Estradiol—osteoporosis	0.00133	0.002	CcSEcCtD
Pasireotide—Anxiety—Estradiol—osteoporosis	0.00132	0.002	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—SOST—osteoporosis	0.00131	0.00388	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—PTH—osteoporosis	0.00131	0.00388	CbGpPWpGaD
Pasireotide—Abdominal pain—Zoledronate—osteoporosis	0.0013	0.00197	CcSEcCtD
Pasireotide—Diarrhoea—Risedronate—osteoporosis	0.0013	0.00196	CcSEcCtD
Pasireotide—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.0013	0.00196	CcSEcCtD
Pasireotide—SSTR5—G alpha (i) signalling events—POMC—osteoporosis	0.0013	0.00384	CbGpPWpGaD
Pasireotide—Asthenia—Pamidronate—osteoporosis	0.00129	0.00196	CcSEcCtD
Pasireotide—Dizziness—Ethinyl Estradiol—osteoporosis	0.00129	0.00195	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—CNR2—osteoporosis	0.00128	0.00378	CbGpPWpGaD
Pasireotide—Pruritus—Pamidronate—osteoporosis	0.00128	0.00193	CcSEcCtD
Pasireotide—Dizziness—Risedronate—osteoporosis	0.00126	0.0019	CcSEcCtD
Pasireotide—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00125	0.0019	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—PTH—osteoporosis	0.00124	0.00367	CbGpPWpGaD
Pasireotide—Vomiting—Ethinyl Estradiol—osteoporosis	0.00124	0.00187	CcSEcCtD
Pasireotide—Diarrhoea—Pamidronate—osteoporosis	0.00123	0.00187	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.00123	0.00365	CbGpPWpGaD
Pasireotide—Headache—Ethinyl Estradiol—osteoporosis	0.00122	0.00184	CcSEcCtD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00121	0.00359	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SOST—osteoporosis	0.00121	0.00358	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—CNR2—osteoporosis	0.00121	0.00358	CbGpPWpGaD
Pasireotide—Vomiting—Risedronate—osteoporosis	0.00121	0.00182	CcSEcCtD
Pasireotide—SSTR2—G alpha (i) signalling events—POMC—osteoporosis	0.0012	0.00354	CbGpPWpGaD
Pasireotide—Dizziness—Pamidronate—osteoporosis	0.00119	0.0018	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—PTH—osteoporosis	0.00119	0.00352	CbGpPWpGaD
Pasireotide—Headache—Risedronate—osteoporosis	0.00119	0.0018	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—CALCR—osteoporosis	0.00119	0.00351	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PTH1R—osteoporosis	0.00119	0.00351	CbGpPWpGaD
Pasireotide—Asthenia—Zoledronate—osteoporosis	0.00118	0.00179	CcSEcCtD
Pasireotide—Pruritus—Zoledronate—osteoporosis	0.00117	0.00176	CcSEcCtD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00116	0.00344	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—PTH—osteoporosis	0.00116	0.00344	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—CNR2—osteoporosis	0.00116	0.00343	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Estradiol—osteoporosis	0.00116	0.00175	CcSEcCtD
Pasireotide—Nausea—Ethinyl Estradiol—osteoporosis	0.00116	0.00175	CcSEcCtD
Pasireotide—Insomnia—Estradiol—osteoporosis	0.00115	0.00174	CcSEcCtD
Pasireotide—Vomiting—Pamidronate—osteoporosis	0.00115	0.00173	CcSEcCtD
Pasireotide—Asthenia—Conjugated Estrogens—osteoporosis	0.00114	0.00172	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—WNT1—osteoporosis	0.00114	0.00337	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—PTHLH—osteoporosis	0.00113	0.00335	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—CNR2—osteoporosis	0.00113	0.00335	CbGpPWpGaD
Pasireotide—Headache—Pamidronate—osteoporosis	0.00113	0.00171	CcSEcCtD
Pasireotide—Diarrhoea—Zoledronate—osteoporosis	0.00113	0.0017	CcSEcCtD
Pasireotide—Nausea—Risedronate—osteoporosis	0.00113	0.0017	CcSEcCtD
Pasireotide—Pruritus—Conjugated Estrogens—osteoporosis	0.00112	0.0017	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—MGLL—osteoporosis	0.00111	0.00328	CbGpPWpGaD
Pasireotide—Decreased appetite—Estradiol—osteoporosis	0.0011	0.00167	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—CALCR—osteoporosis	0.0011	0.00324	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PTH1R—osteoporosis	0.0011	0.00324	CbGpPWpGaD
Pasireotide—Fatigue—Estradiol—osteoporosis	0.0011	0.00165	CcSEcCtD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—TNF—osteoporosis	0.00109	0.00323	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—WNT1—osteoporosis	0.00109	0.00323	CbGpPWpGaD
Pasireotide—Dizziness—Zoledronate—osteoporosis	0.00109	0.00165	CcSEcCtD
Pasireotide—Constipation—Estradiol—osteoporosis	0.00109	0.00164	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—PTHLH—osteoporosis	0.00109	0.00321	CbGpPWpGaD
Pasireotide—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00109	0.00164	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—LRP5—osteoporosis	0.00108	0.0032	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—PTH—osteoporosis	0.00107	0.00317	CbGpPWpGaD
Pasireotide—Nausea—Pamidronate—osteoporosis	0.00107	0.00162	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—MGLL—osteoporosis	0.00106	0.00315	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PTH—osteoporosis	0.00106	0.00312	CbGpPWpGaD
Pasireotide—Dizziness—Conjugated Estrogens—osteoporosis	0.00105	0.00159	CcSEcCtD
Pasireotide—Vomiting—Zoledronate—osteoporosis	0.00105	0.00158	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—CNR2—osteoporosis	0.00105	0.00309	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Estradiol—osteoporosis	0.00104	0.00157	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—LRP5—osteoporosis	0.00104	0.00307	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—LRP6—osteoporosis	0.00104	0.00306	CbGpPWpGaD
Pasireotide—Headache—Zoledronate—osteoporosis	0.00103	0.00156	CcSEcCtD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00103	0.00305	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—PTHLH—osteoporosis	0.00103	0.00304	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CNR2—osteoporosis	0.00103	0.00304	CbGpPWpGaD
Pasireotide—Vomiting—Conjugated Estrogens—osteoporosis	0.00101	0.00152	CcSEcCtD
Pasireotide—Abdominal pain—Estradiol—osteoporosis	0.001	0.00152	CcSEcCtD
Pasireotide—SSTR3—GPCR downstream signaling—CALCA—osteoporosis	0.000997	0.00295	CbGpPWpGaD
Pasireotide—Headache—Conjugated Estrogens—osteoporosis	0.000994	0.0015	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—LRP6—osteoporosis	0.000993	0.00294	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—PTHLH—osteoporosis	0.000986	0.00292	CbGpPWpGaD
Pasireotide—Nausea—Zoledronate—osteoporosis	0.000979	0.00148	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—PTH—osteoporosis	0.000974	0.00288	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—WNT1—osteoporosis	0.000967	0.00286	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—PTHLH—osteoporosis	0.000963	0.00285	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—CALCA—osteoporosis	0.000956	0.00283	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000952	0.00281	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CNR2—osteoporosis	0.000949	0.00281	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MGLL—osteoporosis	0.000943	0.00279	CbGpPWpGaD
Pasireotide—Nausea—Conjugated Estrogens—osteoporosis	0.000943	0.00142	CcSEcCtD
Pasireotide—SSTR3—GPCR ligand binding—POMC—osteoporosis	0.000923	0.00273	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—LRP5—osteoporosis	0.000921	0.00272	CbGpPWpGaD
Pasireotide—Asthenia—Estradiol—osteoporosis	0.000911	0.00138	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—CALCA—osteoporosis	0.000906	0.00268	CbGpPWpGaD
Pasireotide—Pruritus—Estradiol—osteoporosis	0.000899	0.00136	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—TNF—osteoporosis	0.000894	0.00265	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—WNT1—osteoporosis	0.000893	0.00264	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—PTHLH—osteoporosis	0.000889	0.00263	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—POMC—osteoporosis	0.000885	0.00262	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—IL6—osteoporosis	0.000882	0.00261	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—LRP6—osteoporosis	0.000881	0.0026	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PTHLH—osteoporosis	0.000875	0.00259	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TLN1—osteoporosis	0.000874	0.00259	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MGLL—osteoporosis	0.00087	0.00257	CbGpPWpGaD
Pasireotide—Diarrhoea—Estradiol—osteoporosis	0.000869	0.00131	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—CALCA—osteoporosis	0.000868	0.00257	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—LRP5—osteoporosis	0.00085	0.00251	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—CALCA—osteoporosis	0.000848	0.00251	CbGpPWpGaD
Pasireotide—Dizziness—Estradiol—osteoporosis	0.00084	0.00127	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—TLN1—osteoporosis	0.000838	0.00248	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—LRP6—osteoporosis	0.000813	0.0024	CbGpPWpGaD
Pasireotide—Vomiting—Estradiol—osteoporosis	0.000808	0.00122	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—PTHLH—osteoporosis	0.000807	0.00239	CbGpPWpGaD
Pasireotide—Headache—Estradiol—osteoporosis	0.000796	0.0012	CcSEcCtD
Pasireotide—SSTR5—GPCR ligand binding—POMC—osteoporosis	0.000785	0.00232	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—CALCA—osteoporosis	0.000783	0.00232	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CALCA—osteoporosis	0.00077	0.00228	CbGpPWpGaD
Pasireotide—Nausea—Estradiol—osteoporosis	0.000755	0.00114	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—P4HB—osteoporosis	0.000754	0.00223	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TLN1—osteoporosis	0.000744	0.0022	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PTH—osteoporosis	0.000733	0.00217	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—POMC—osteoporosis	0.000725	0.00214	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—P4HB—osteoporosis	0.000723	0.00214	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—IL6—osteoporosis	0.000722	0.00214	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—RAP1A—osteoporosis	0.000721	0.00213	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CNR2—osteoporosis	0.000715	0.00211	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CALCA—osteoporosis	0.000711	0.0021	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—ADCY5—osteoporosis	0.00071	0.0021	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NFATC1—osteoporosis	0.000703	0.00208	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PTH—osteoporosis	0.000703	0.00208	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—DKK1—osteoporosis	0.000698	0.00206	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—RAP1A—osteoporosis	0.000691	0.00204	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TLN1—osteoporosis	0.000686	0.00203	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CNR2—osteoporosis	0.000685	0.00203	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—ADCY5—osteoporosis	0.00068	0.00201	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NFATC1—osteoporosis	0.000674	0.00199	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—WNT1—osteoporosis	0.000672	0.00199	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—DKK1—osteoporosis	0.000669	0.00198	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—FGA—osteoporosis	0.000654	0.00193	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—WNT1—osteoporosis	0.000644	0.00191	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—ADCY5—osteoporosis	0.000644	0.00191	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—P4HB—osteoporosis	0.000641	0.0019	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—FGA—osteoporosis	0.000627	0.00185	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PTH—osteoporosis	0.000624	0.00184	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—ADCY5—osteoporosis	0.000618	0.00183	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—RAP1A—osteoporosis	0.000613	0.00181	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CNR2—osteoporosis	0.000608	0.0018	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—BMP2—osteoporosis	0.000608	0.0018	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PTHLH—osteoporosis	0.000608	0.0018	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—ADCY5—osteoporosis	0.000603	0.00178	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NFATC1—osteoporosis	0.000598	0.00177	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—FGB—osteoporosis	0.000595	0.00176	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—DKK1—osteoporosis	0.000593	0.00175	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—P4HB—osteoporosis	0.000592	0.00175	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—BMP2—osteoporosis	0.000583	0.00172	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PTHLH—osteoporosis	0.000583	0.00172	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PTH—osteoporosis	0.000576	0.0017	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PSMA2—osteoporosis	0.000574	0.0017	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PSMA5—osteoporosis	0.000574	0.0017	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—WNT1—osteoporosis	0.000571	0.00169	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—FGB—osteoporosis	0.00057	0.00169	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—RAP1A—osteoporosis	0.000566	0.00167	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CNR2—osteoporosis	0.000561	0.00166	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—ADCY5—osteoporosis	0.000557	0.00165	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—FGA—osteoporosis	0.000556	0.00164	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NFATC1—osteoporosis	0.000552	0.00163	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PSMA5—osteoporosis	0.00055	0.00163	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PSMA2—osteoporosis	0.00055	0.00163	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—ADCY5—osteoporosis	0.000548	0.00162	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—DKK1—osteoporosis	0.000547	0.00162	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CALCA—osteoporosis	0.000535	0.00158	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—WNT1—osteoporosis	0.000527	0.00156	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—POMC—osteoporosis	0.000522	0.00154	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—BMP2—osteoporosis	0.000517	0.00153	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PTHLH—osteoporosis	0.000517	0.00153	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CALCA—osteoporosis	0.000513	0.00152	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—FGA—osteoporosis	0.000513	0.00152	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—FGB—osteoporosis	0.000506	0.0015	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—ADCY5—osteoporosis	0.000506	0.0015	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—POMC—osteoporosis	0.0005	0.00148	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PSMA2—osteoporosis	0.000488	0.00144	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PSMA5—osteoporosis	0.000488	0.00144	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—KL—osteoporosis	0.000486	0.00144	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PTHLH—osteoporosis	0.000477	0.00141	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—BMP2—osteoporosis	0.000477	0.00141	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—POMC—osteoporosis	0.000474	0.0014	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—FGB—osteoporosis	0.000467	0.00138	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—KL—osteoporosis	0.000466	0.00138	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—IL6R—osteoporosis	0.000462	0.00137	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CALCA—osteoporosis	0.000455	0.00135	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—POMC—osteoporosis	0.000454	0.00134	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PSMA2—osteoporosis	0.000451	0.00133	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PSMA5—osteoporosis	0.000451	0.00133	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—POMC—osteoporosis	0.000444	0.00131	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—IL6R—osteoporosis	0.000443	0.00131	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CALCA—osteoporosis	0.00042	0.00124	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—KL—osteoporosis	0.000413	0.00122	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—POMC—osteoporosis	0.00041	0.00121	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—POMC—osteoporosis	0.000403	0.00119	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL6R—osteoporosis	0.000393	0.00116	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—KL—osteoporosis	0.000381	0.00113	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—ADCY5—osteoporosis	0.000381	0.00113	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—POMC—osteoporosis	0.000372	0.0011	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SPP1—osteoporosis	0.000368	0.00109	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—ADCY5—osteoporosis	0.000365	0.00108	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL6R—osteoporosis	0.000363	0.00107	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SPP1—osteoporosis	0.000353	0.00104	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IRS2—osteoporosis	0.000333	0.000985	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—LEP—osteoporosis	0.000326	0.000964	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—ADCY5—osteoporosis	0.000324	0.000957	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IRS2—osteoporosis	0.000319	0.000944	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SPP1—osteoporosis	0.000313	0.000926	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—LEP—osteoporosis	0.000312	0.000924	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—ESR1—osteoporosis	0.000311	0.00092	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ADCY5—osteoporosis	0.000299	0.000883	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—ESR1—osteoporosis	0.000298	0.000882	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IRS1—osteoporosis	0.000291	0.00086	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SPP1—osteoporosis	0.000289	0.000855	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IRS2—osteoporosis	0.000283	0.000838	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—POMC—osteoporosis	0.00028	0.000828	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IRS1—osteoporosis	0.000279	0.000824	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—LEP—osteoporosis	0.000277	0.00082	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL6R—osteoporosis	0.000273	0.000808	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IGF1—osteoporosis	0.000269	0.000797	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—POMC—osteoporosis	0.000268	0.000794	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—ESR1—osteoporosis	0.000265	0.000783	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL6R—osteoporosis	0.000262	0.000774	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IRS2—osteoporosis	0.000261	0.000773	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IGF1—osteoporosis	0.000258	0.000764	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—LEP—osteoporosis	0.000256	0.000756	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IRS1—osteoporosis	0.000247	0.000731	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ESR1—osteoporosis	0.000244	0.000722	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—POMC—osteoporosis	0.000238	0.000704	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL6R—osteoporosis	0.000232	0.000687	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IGF1—osteoporosis	0.000229	0.000677	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IRS1—osteoporosis	0.000228	0.000675	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—POMC—osteoporosis	0.00022	0.00065	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL6R—osteoporosis	0.000214	0.000634	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IGF1—osteoporosis	0.000211	0.000625	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—IL6—osteoporosis	0.000206	0.000609	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—IL6—osteoporosis	0.000197	0.000584	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL6—osteoporosis	0.000175	0.000518	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MYC—osteoporosis	0.000162	0.000479	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL6—osteoporosis	0.000162	0.000478	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TGFB1—osteoporosis	0.000161	0.000478	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MYC—osteoporosis	0.000155	0.000459	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TGFB1—osteoporosis	0.000155	0.000458	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MYC—osteoporosis	0.000138	0.000407	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TGFB1—osteoporosis	0.000137	0.000406	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MYC—osteoporosis	0.000127	0.000376	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TGFB1—osteoporosis	0.000127	0.000375	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL6—osteoporosis	0.000122	0.00036	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL6—osteoporosis	0.000117	0.000345	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL6—osteoporosis	0.000103	0.000306	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL6—osteoporosis	9.55e-05	0.000282	CbGpPWpGaD
